KA

Kumari Aarti

Active Director Director DIN 08810058
DIN 08810058 First appointment Jul 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Kumari Aarti

Data last updated:

Kumari Aarti is a Director at Shivaxy Pharmaceuticals Private Limited (since 2020). The company operates in Pharma. Shivaxy Pharmaceuticals Private Limited reported revenue of ₹1.97 Cr (FY 2025).

DIN 08810058
Primary Designation Director
Industry Pharma
First Appointment 27 Jul 2020
Oldest Company Age 6 yrs
Largest company Shivaxy Pharmaceuticals Private Limited · ₹1.97 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jul 20202020₹1.97 Cr (FY 2025)Active

Board colleagues of Kumari Aarti

NameDINCompanyDesignation
Gaurav Sharma08810059Shivaxy Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shivaxy Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kumari Aarti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumari Aarti

Kumari Aarti currently holds 1 directorship: Shivaxy Pharmaceuticals Private Limited (Director, since 27 Jul 2020, revenue ₹1.97 Cr (FY 2025)).

Kumari Aarti was first appointed on 27 Jul 2020 as Director at Shivaxy Pharmaceuticals Private Limited.

The current boards of Kumari Aarti's companies include Gaurav Sharma (Shivaxy Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available